Diffuse cholesteatosis
ICD-10 H71.3 is a billable code used to indicate a diagnosis of diffuse cholesteatosis.
Diffuse cholesteatosis is a condition characterized by the abnormal accumulation of cholesteatoma tissue in the middle ear and mastoid process. This condition often arises as a complication of chronic otitis media, where the persistent inflammation leads to the formation of a cyst-like sac filled with skin cells and other debris. Clinically, patients may present with symptoms such as hearing loss, ear fullness, and recurrent ear infections. The presence of cholesteatoma can erode surrounding structures, leading to potential complications such as mastoiditis or even intracranial infections if left untreated. Diagnosis typically involves otoscopic examination, imaging studies like CT scans, and audiometric testing to assess hearing loss. Management often requires surgical intervention to remove the cholesteatoma and reconstruct the tympanic membrane, with the goal of restoring hearing and preventing further complications. Postoperative follow-up is crucial to monitor for recurrence and manage any residual hearing loss.
Detailed history of ear symptoms, audiometric results, and imaging studies.
Patients presenting with recurrent ear infections, hearing loss, or complications from chronic otitis media.
Ensure documentation reflects the extent of the cholesteatoma and any surgical interventions performed.
Audiometric evaluations and reports on hearing loss related to cholesteatosis.
Assessment of hearing loss in patients with a history of cholesteatoma.
Document the impact of cholesteatosis on hearing and any recommendations for further intervention.
Performed to remove cholesteatoma and reconstruct the tympanic membrane.
Operative report detailing the procedure and findings.
Otolaryngology specialists should ensure all findings are documented.
Common symptoms include hearing loss, ear fullness, and recurrent ear infections. Patients may also experience pain and drainage from the ear.
Diagnosis is typically made through a combination of clinical history, otoscopic examination, audiometric testing, and imaging studies such as CT scans.
Treatment usually involves surgical intervention to remove the cholesteatoma and reconstruct the tympanic membrane, along with management of any associated infections.
